Can ischemia-modified albumin be used as an objective biomarker for renal ischemic damage?
This study shows that IMA levels can be used as a nonselective biomarker for renal ischemic injury. However, further studies are needed to support our findings.
Based on this large retrospective review, properly applied Hem-o-lock clips for vascular control during renal procedures may provide a safe option.